GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE272nnn/GSE272293/primaryOK200TranscriptomicsMus musculusExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272293GEOGSEfalseREV-ERBs agonist SR9009 inhibits liver fibrosis progression in a MASH fibrosis model invivo.To explore the CC as a therapeutic target for MASH-induced fibrosis, we studied whether SR9009, a pharmacological activator of REV-ERBα, modulates fibrosis in CDA-HFD fed C57Bl/6J mice, a state-of-the-art model for MASH fibrosis2026/07/17GSE272293GSM8397936GSM8397925GSM8397926GSM8397937GSM8397934GSM8397935GSM8397929GSM8397938GSM8397927GSM8397928GSM8397939GSM8397932GSM8397933GSM8397930GSM839793134290272293Mus musculus[39173955]